I-ACT for Children Adds 2 Members to their Board of Directors
I-ACT for Children is pleased to announce two additional appointments to the Board of Directors. Daniel M. Jorgensen, MD, MPH, MBA and Tamorah Lewis, MD, PhD were introduced to the Board of Directors for their first meeting in February 2023. Dr. Jorgensen is an accomplished physician executive with 25 years of experience in the biopharmaceutical…
Read MoreIBD Webinar Series: Clinical Trial Designs and Relevant Discussion Points From the Previous Three Webinars
The wish of pediatricians: More medications deemed safe for kids A paucity of drugs approved for children forces doctors to prescribe ‘off-label’ and figure out doses. New ways to run clinical trials are yielding more pediatric medications. By Patrick Boyle, Senior Staff Writer June 21, 2022 Like just about every pediatrician, Danny Benjamin, MD, PhD, is…
Read More